leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 01:38:22 - browse：9537

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Biden's 'march

hotspot

WSS

Food makers to regulators: Ultra

Popular nasal decongestant doesn't actually relieve congestion

New Covid vaccine is recommended for everyone 6 months or older

Fetal cell organoids grown from amniotic fluid, study finds

PEPFAR is under serious threat — and so is global health

Harvard's David Sinclair gets blowback over aging

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why Talkspace is targeting Medicare, a tricky market

Continuity nursing helped my family in our darkest PICU moments

Stem cell biologist probes earliest stages of human development

Jerome Adams on the need for new antivirals for Covid

FDA approves updated Covid vaccines

Medical leaders decry Supreme Court decision on affirmative action

Telehealth for opioid use disorder is lifesaving

Apple is now the first public company to be valued at $3 trillion

PEPFAR is under serious threat — and so is global health

focus

WATCH: Why do bright lights make us see spots?

Microsoft's Peter Lee: Generative AI could help doctors be more human

Ancient Greek ideas underpin modern concepts of pregnancy

Popular nasal decongestant doesn't actually relieve congestion

State of the Union pitch: Bigger Medicare drug price negotiations

First over

leisure time

hotspot

knowledge

Wikipedia